Systemic inflammation impacts outcome after traumatic brain injury (TBI), but most TBI
biomarker studies have focused on brain-specific proteins. C-reactive protein (CRP) is a …

Objective: A panel of biomarkers is needed to definitively diagnose mild traumatic brain
injury (mTBI). There is a clear role for the inclusion of an inflammatory biomarker. This study …

The relationship between systemic inflammation and secondary injury in traumatic brain
injury (TBI) is complex. We investigated associations between inflammatory markers and …

Abstract Traumatic Brain Injury (TBI) triggers a cascade of secondary biological and
physiological effects that are variable, depending on the severity, location, and complexity of …

Objective Activation of the inflammatory cascade is a known pathophysiologic process in
severe traumatic brain injury (TBI) with yet non-standardized scientific data regarding …

Studies have characterized absolute levels of multiple inflammatory markers as significant
risk factors for poor outcomes after traumatic brain injury (TBI). However, inflammatory …

Traumatic brain injury (TBI) has a complex pathology in which the initial injury releases
damage associated proteins that exacerbate the neuroinflammatory response during the …

The pathogenesis of persistent unfavourable outcomes following mild traumatic brain injury
(mTBI) are not fully understood. Low-grade systemic inflammation might contribute to the …

Abstract VISSER, K., M. Koggel, J. Blaauw, HJvd Horn, B. Jacobs, and Jvd Naalt. Blood
based biomarkers of inflammation in mild traumatic brain injury: A systematic review …

Despite pre-clinical evidence for the role of inflammation in traumatic brain injury (TBI), there
is limited data on inflammatory biomarkers in mild TBI (mTBI). In this study, we describe the …